Fatimah S Alshahrani - Infectious Diseases

Author Information

Fatimah S Alshahrani is affiliated with the Division of Infectious Diseases, Department of Internal Medicine, College of Medicine at King Saud University and King Saud University Medical City in Riyadh, Saudi Arabia. Her academic and research pursuits are deeply embedded within the field of Infectious Diseases, where she contributes to both the educational and practical applications of medical science.

Research Contributions

Fatimah S Alshahrani has made significant contributions to the understanding and management of infectious diseases, particularly in the context of the COVID-19 pandemic. Her research explores various dimensions of healthcare, including the performance and empowerment of healthcare workers during the pandemic, the impact and perception of COVID-19 variants and vaccines, and the integration of mobile technology for public health surveillance. She has also investigated the treatment of drug-resistant infections and the nuances of COVID-19 transmission and reinfection.

Aliases

The author is known by several aliases in the academic community, including F. Alshahrani, Fatimah Alshahrani, Fatimah S Alshahrani, and Fatima Alshahrani. These variations in her name are used across different publications and platforms.

Publication and Citation Metrics

Metric	Value
Citation Count	454
H-index	12
Paper Count	28

Publications:

The Effects of Empowerment on Health Care Worker Performance During the COVID-19 Pandemic in Saudi Arabia.

DOI: 10.1097/QMH.0000000000000337

Year: 2022

SARS-CoV-2 Omicron Variant: Exploring Healthcare Workers' Awareness and Perception of Vaccine Effectiveness: A National Survey During the First Week of WHO Variant Alert

DOI: 10.3389/fpubh.2022.878159

Year: 2022

Healthcare Workers’ SARS-CoV-2 Omicron Variant Uncertainty-Related Stress, Resilience, and Coping Strategies during the First Week of the World Health Organization’s Alert

DOI: 10.3390/ijerph19041944

Year: 2022

Ceftolozane-tazobactam versus colistin for the treatment of infections due to drug-resistant Pseudomonas aeruginosa. A multicenter cohort study.

DOI: 10.1016/j.jgar.2022.01.023

Year: 2022

Mobile Apps for COVID-19 Surveillance: Balancing Public Health Needs with the Privacy of Personal Data

DOI: 10.2139/ssrn.3953393

Year: 2021

Parental Attitudes and Hesitancy About COVID-19 vs. Routine Childhood Vaccinations: A National Survey

DOI: 10.3389/fpubh.2021.752323

Year: 2021

SARS-CoV-2 Omicron variant: healthcare workers' perceptions and beliefs of vaccine effectiveness and advocacy: a national survey during the first week of the World Health Organization variant alert

DOI: 10.1101/2021.12.27.21268431

Year: 2021

Airborne transmission of SARS-CoV-2 is the dominant route of transmission: droplets and aerosols.

DOI:

Year: 2021

Mobile Apps for COVID-19 Surveillance: Balancing Public Health Needs with the Privacy of Personal Data under the Saudi Arabian Laws

DOI: 10.31219/osf.io/akrzh

Year: 2021

Reinfection, recurrence, or delayed presentation of COVID-19? Case series and review of the literature

DOI: 10.1016/j.jiph.2021.01.002

Year: 2021

How Does Aedes Aegypti Transmit Diseases?

What are the Challenges in Genomic and Proteomic Studies?

How Do Metabolic Pathways Influence Immune Response?

How is HFMD Transmitted?

What are Artemisinin-Based Combination Therapies (ACTs)?

What is the Role of Public Health in Managing Gonorrhea?

What is Reverse Transcription Polymerase Chain Reaction (RT-PCR)?

What are Direct Acting Antivirals (DAAs)?

How Can Couples Stay Safe in a Monogamous Relationship?

What are the Benefits of Gene Therapy and Immunotherapy?

Partnered Content Networks

Relevant Topics